Neurocrine Biosciences, Inc. (NBIX)
153.04
+0.47
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
153.04
0.00 (0.00%)
After-Hours: 19:20
Neurocrine Biosciences Total Liabilities (Quarterly) : 1.666B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.666B |
| March 31, 2026 | 1.499B |
| December 31, 2025 | 1.500B |
| September 30, 2025 | 1.262B |
| June 30, 2025 | 1.196B |
| March 31, 2025 | 1.152B |
| December 31, 2024 | 1.257B |
| September 30, 2024 | 816.10M |
| June 30, 2024 | 795.80M |
| March 31, 2024 | 1.086B |
| December 31, 2023 | 1.098B |
| September 30, 2023 | 846.10M |
| June 30, 2023 | 760.10M |
| March 31, 2023 | 675.30M |
| December 31, 2022 | 693.70M |
| September 30, 2022 | 598.80M |
| June 30, 2022 | 582.30M |
| March 31, 2022 | 753.40M |
| December 31, 2021 | 698.50M |
| September 30, 2021 | 671.30M |
| June 30, 2021 | 677.20M |
| March 31, 2021 | 640.80M |
| December 31, 2020 | 608.50M |
| September 30, 2020 | 698.30M |
| June 30, 2020 | 684.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 661.60M |
| December 31, 2019 | 669.12M |
| September 30, 2019 | 605.42M |
| June 30, 2019 | 583.16M |
| March 31, 2019 | 548.45M |
| December 31, 2018 | 512.39M |
| September 30, 2018 | 486.23M |
| June 30, 2018 | 463.88M |
| March 31, 2018 | 441.87M |
| December 31, 2017 | 445.45M |
| September 30, 2017 | 424.98M |
| June 30, 2017 | 408.85M |
| March 31, 2017 | 42.22M |
| December 31, 2016 | 50.21M |
| September 30, 2016 | 47.51M |
| June 30, 2016 | 48.80M |
| March 31, 2016 | 46.37M |
| December 31, 2015 | 50.33M |
| September 30, 2015 | 45.49M |
| June 30, 2015 | 44.26M |
| March 31, 2015 | 43.05M |
| December 31, 2014 | 34.33M |
| September 30, 2014 | 33.71M |
| June 30, 2014 | 32.69M |
| March 31, 2014 | 32.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amarin Corp. Plc | 180.75M |
| Liquidia Corp. | 326.80M |
| Incyte Corp. | 1.528B |
| Krystal Biotech, Inc. | 141.52M |
| Halozyme Therapeutics, Inc. | 2.434B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.359B |
| Shareholders Equity (Quarterly) | 3.694B |
| Debt to Equity Ratio | 0.1088 |
| Current Ratio | 1.872 |
| Net Debt Paydown Yield | 0.11% |